Clients

ENDRA Life Sciences Inc.

Company Snapshot: ENDRA Life Sciences Inc.

NDRA
Last Change Volume High Low

Company Overview

ENDRA Life Sciences Inc. develops technology for clinical diagnostic ultrasound. The company develops thermo-acoustic enhanced ultrasound technology that transmits sound waves, which bounce off tissues, organs, and blood for the treatment of nonalcoholic fatty liver disease, as well as temperature monitoring of thermoablative surgery, vascular imaging, and tissue perfusion. It also offers diagnostic imaging technologies, such as computed tomography, magnetic resonance imaging, and ultrasound that allow physicians to look inside a person's body to guide treatment or gather information about medical conditions, such as broken bones, cancers, signs of heart disease, or internal bleeding. The company has a collaborative research agreement with General Electric Company. ENDRA Life Sciences Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan.

Client News

  1. Nov 14 2022 ENDRA Life Sciences Reports Third Quarter 2022 Financial Results and Provides Business Update
  2. Nov 9 2022 ENDRA Life Sciences to Report Third Quarter 2022 Financial Results on November 14, 2022
  3. Oct 25 2022 ENDRA Life Sciences Enhances TAEUS® System Intellectual Property Portfolio with Issuance of Two U.S. Patents
  4. Oct 4 2022 ENDRA Life Sciences to Participate in the H.C. Wainwright 6th Annual NASH Investor Conference